Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s10147-017-1118-x
Published Online: 2017-04-05
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kobayashi, Haruki
Omori, Shota
Nakashima, Kazuhisa
Wakuda, Kazushige
Ono, Akira
Kenmotsu, Hirotsugu
Naito, Tateaki
Murakami, Haruyasu
Endo, Masahiro
Takahashi, Toshiaki
License valid from 2017-04-05